TARS vs BIIB: Which Stock is Better?
Side-by-side comparison of Tarsus Pharmaceuticals Inc and Biogen Inc in 2026
TARS
Tarsus Pharmaceuticals Inc
$67.72
BIIB
Biogen Inc
$176.02
Key Metrics Comparison
| Metric | TARS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $3.06B | $25.83B | BIIB |
| P/E Ratio | N/A | 20.05 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 1.3% | -0.1% | TARS |
| Gross Margin | 79.0% | 78.9% | TARS |
Analyze TARS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TARS or BIIB a better investment?
Comparing TARS and BIIB: Tarsus Pharmaceuticals Inc has a market cap of $3.06B while Biogen Inc has $25.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TARS and BIIB?
TARS (Tarsus Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TARS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TARS or BIIB?
TARS has higher revenue growth at 1.3% vs -0.1% for BIIB.
Which company is more profitable: TARS or BIIB?
Tarsus Pharmaceuticals Inc (TARS) has higher gross margins at 79.0% compared to 78.9% for BIIB.
Which is the larger company: TARS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.83B compared to $3.06B for TARS.
Should I buy TARS or BIIB in 2026?
Both TARS and BIIB have investment merit. TARS trades at $67.72 while BIIB trades at $176.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TARS and BIIB stock?
Key differences: Market Cap ($3.06B vs $25.83B), P/E Ratio (N/A vs 20.0x), Revenue Growth (1.3% vs -0.1%), Gross Margin (79.0% vs 78.9%).